Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of Ataxia-Telangiectasia Mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancer

Inhibitors of Ataxia-Telangiectasia Mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancer

US Patent 12233060 · Granted Feb 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modular tailgate2025
Modular lighting systems for exterior surface architecture2024
Compositions and methods for scavenging hydrogen sulfide2024
Modular tailgate2022
Two-stage biomass pyrolysis2019
Systems for two-stage biomass pyrolysis2018
Increasing stability of a pyrolysis product2017
3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use2017
Bio-oil fractionation and condensation2017
3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use2015
Selective temperature quench and electrostatic recovery of bio-oil fractions2015
Systems and methods for processing color information in spreadsheets2013